69 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
investigation, on the Schedule 13G/A filed by the Bain Capital Life Science Entities with the SEC on February 13, 2024.
BCLS Fund II owns warrants … the Bain Capital Life Science Entities, we have relied, without independent investigation, on the Schedule 13G/A filed by the Bain Capital Life Science
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal … , is subject to a governmental inquiry, investigation, proceeding, or other similar action that would reasonably be expected to result in debarment, suspension
8-K
EX-99.1
1p77 jip45y
25 May 23
Regulation FD Disclosure
5:10pm
8-K
EX-99.1
wu8xic4pd9
12 Dec 22
Regulation FD Disclosure
7:48am
S-8
j4eap
16 Sep 22
Registration of securities for employees
7:50am
424B3
hl8ima
8 Aug 22
Prospectus supplement
5:47pm
S-4
jhq42c 1kc6pv5
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
es7dr
6 Jul 22
Business combination disclosure
4:30pm